These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 25289657

  • 21. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization.
    Tong JP, Chan WM, Liu DT, Lai TY, Choy KW, Pang CP, Lam DS.
    Am J Ophthalmol; 2006 Mar; 141(3):456-62. PubMed ID: 16490490
    [Abstract] [Full Text] [Related]

  • 22. Long-term functional and morphologic retinal changes after ranibizumab and photodynamic therapy in myopic choroidal neovascularization.
    Parravano M, Ricci F, Oddone F, Missiroli F, De Felici C, Varano M.
    Retina; 2014 Oct; 34(10):2053-62. PubMed ID: 24946101
    [Abstract] [Full Text] [Related]

  • 23. Anti-VEGF therapy in myopic choroidal neovascularization: long-term results.
    Freitas-da-Costa P, Pinheiro-Costa J, Carvalho B, Falcão M, Brandão E, Falcão-Reis F, Carneiro Â.
    Ophthalmologica; 2014 Oct; 232(1):57-63. PubMed ID: 24852069
    [Abstract] [Full Text] [Related]

  • 24. [Role of immunological factors in the development of myopic choroidal neovascularization].
    Shchuko AG, Zaytseva NV, Yur'eva TN, Chernykh ER, Mikhalevich IM, Grigor'eva AV.
    Vestn Oftalmol; 2016 Oct; 132(5):5-14. PubMed ID: 27911420
    [Abstract] [Full Text] [Related]

  • 25. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.
    Chan WM, Lai TY, Liu DT, Lam DS.
    Ophthalmology; 2007 Dec; 114(12):2190-6. PubMed ID: 17599414
    [Abstract] [Full Text] [Related]

  • 26. MYOPIC CHOROIDAL NEOVASCULARIZATION: Diagnosis and Treatment.
    Lai TY, Cheung CM.
    Retina; 2016 Sep; 36(9):1614-21. PubMed ID: 27482641
    [Abstract] [Full Text] [Related]

  • 27. Intravitreal bevacizumab vs sub-tenon triamcinolone acetonide for choroidal neovascularization attributable to pathologic myopia.
    Wakabayashi T, Ikuno Y, Gomi F, Hamasaki T, Tano Y.
    Am J Ophthalmol; 2009 Oct; 148(4):591-596.e1. PubMed ID: 19589497
    [Abstract] [Full Text] [Related]

  • 28. Different dosing of intravitreal bevacizumab for choroidal neovascularization because of pathologic myopia.
    Wakabayashi T, Ikuno Y, Gomi F.
    Retina; 2011 May; 31(5):880-6. PubMed ID: 21242860
    [Abstract] [Full Text] [Related]

  • 29. Fluorescein angiography and spectral-domain optical coherence tomography for monitoring anti-VEGF therapy in myopic choroidal neovascularization.
    Iacono P, Battaglia Parodi M, Papayannis A, Kontadakis S, Da Pozzo S, Cascavilla ML, La Spina C, Varano M, Bandello F.
    Ophthalmic Res; 2014 May; 52(1):25-31. PubMed ID: 24861045
    [Abstract] [Full Text] [Related]

  • 30. PREDICTING LESION SHRINKAGE IN EYES WITH MYOPIC CHOROIDAL NEOVASCULARIZATION FROM FEATURES ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
    Liu J, Song S, Yu X.
    Retina; 2022 Sep 01; 42(9):1665-1672. PubMed ID: 35594547
    [Abstract] [Full Text] [Related]

  • 31. One-year outcome of two different initial dosing regimens of intravitreal ranibizumab for myopic choroidal neovascularization.
    Kung YH, Wu TT, Huang YH.
    Acta Ophthalmol; 2014 Dec 01; 92(8):e615-20. PubMed ID: 24924911
    [Abstract] [Full Text] [Related]

  • 32. Choroidal neovascularization secondary to pathological myopia-macular Bruch membrane defects as prognostic factor to anti-VEGF treatment.
    Coelho J, Ferreira A, Abreu AC, Monteiro S, Furtado MJ, Gomes M, Lume M.
    Graefes Arch Clin Exp Ophthalmol; 2021 Sep 01; 259(9):2679-2686. PubMed ID: 33744983
    [Abstract] [Full Text] [Related]

  • 33. Anti-VEGF drugs as the 2009 first-line therapy for choroidal neovascularization in pathologic myopia.
    Cohen SY.
    Retina; 2009 Sep 01; 29(8):1062-6. PubMed ID: 19734760
    [Abstract] [Full Text] [Related]

  • 34. Correlation of macular choroidal thickness with concentrations of aqueous vascular endothelial growth factor in high myopia.
    Chen W, Song H, Xie S, Han Q, Tang X, Chu Y.
    Curr Eye Res; 2015 Mar 01; 40(3):307-13. PubMed ID: 25300046
    [Abstract] [Full Text] [Related]

  • 35. Retinal pigmental epithelium elevation and external limiting membrane interruption in myopic choroidal neovascularization: correlation with activity.
    Ding X, Zhan Z, Sun L, Yang Y, Li S, Zhang A, Luo X, Lu L.
    Graefes Arch Clin Exp Ophthalmol; 2018 Oct 01; 256(10):1831-1837. PubMed ID: 29982899
    [Abstract] [Full Text] [Related]

  • 36. Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results.
    Gharbiya M, Allievi F, Mazzeo L, Gabrieli CB.
    Am J Ophthalmol; 2009 Jan 01; 147(1):84-93.e1. PubMed ID: 18774547
    [Abstract] [Full Text] [Related]

  • 37. Myopic choroidal neovascularization.
    Ruiz-Moreno JM, López-Gálvez MI, Donate J, Gomez-Ulla F, García-Arumí J, García-Layana A, Sellés I, Reche J, Montero JA, Pazos B, Zapata MA, Pastor JC.
    Ophthalmology; 2011 Dec 01; 118(12):2521-3. PubMed ID: 22136676
    [No Abstract] [Full Text] [Related]

  • 38. Retinal vascular changes and aqueous humor cytokines changes after aflibercept intravitreal injection in treatment-naïve myopic choroidal neovascularization.
    Di Antonio L, Toto L, Mastropasqua A, Brescia L, Erroi E, Lamolinara A, Di Nicola M, Mastropasqua L.
    Sci Rep; 2018 Oct 23; 8(1):15631. PubMed ID: 30353107
    [Abstract] [Full Text] [Related]

  • 39. Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy.
    Hayashi K, Ohno-Matsui K, Teramukai S, Shimada N, Moriyama M, Hayashi W, Yoshida T, Tokoro T, Mochizuki M.
    Am J Ophthalmol; 2009 Sep 23; 148(3):396-408. PubMed ID: 19427991
    [Abstract] [Full Text] [Related]

  • 40. Ocular risk factors for recurrence of myopic choroidal neovascularization: long-term follow-up study.
    Kang HM, Koh HJ.
    Retina; 2013 Sep 23; 33(8):1613-22. PubMed ID: 23591527
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.